BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21421314)

  • 1. Prediction of biological activity of Aurora-A kinase inhibitors by multilinear regression analysis and support vector machine.
    Yan A; Chong Y; Wang L; Hu X; Wang K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2238-43. PubMed ID: 21421314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure and bioactivity relationship study on human acetylcholinesterase inhibitors.
    Yan A; Wang K
    Bioorg Med Chem Lett; 2012 May; 22(9):3336-42. PubMed ID: 22460031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine.
    Xuan S; Wu Y; Chen X; Liu J; Yan A
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1648-55. PubMed ID: 23395655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Aurora kinase inhibitors by self-organizing map (SOM) and support vector machine (SVM).
    Yan A; Nie X; Wang K; Wang M
    Eur J Med Chem; 2013 Mar; 61():73-83. PubMed ID: 22796044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of bioactivity of ACAT2 inhibitors by multilinear regression analysis and support vector machine.
    Zhong M; Xuan S; Wang L; Hou X; Wang M; Yan A; Dai B
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3788-92. PubMed ID: 23711921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM).
    Qin Z; Wang M; Yan A
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2931-2938. PubMed ID: 28501513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
    Cormanich RA; Goodarzi M; Freitas MP
    Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational models on quantitative prediction of bioactivity of HIV-1 integrase 3' processing inhibitors.
    Kong Y; Xuan S; Yan A
    SAR QSAR Environ Res; 2014; 25(9):729-46. PubMed ID: 25121566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
    Qin J; Xi L; Du J; Liu H; Yao X
    Chem Biol Drug Des; 2010 Dec; 76(6):527-37. PubMed ID: 21040493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of sweetness by multilinear regression analysis and support vector machine.
    Zhong M; Chong Y; Nie X; Yan A; Yuan Q
    J Food Sci; 2013 Sep; 78(9):S1445-50. PubMed ID: 23915005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.
    Lan P; Chen WN; Chen WM
    Eur J Med Chem; 2011 Jan; 46(1):77-94. PubMed ID: 21093113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of Aurora-A Kinase Inhibitors Using Self-Organizing Map (SOM) and Support Vector Machine (SVM).
    Wang L; Wang Z; Yan A; Yuan Q
    Mol Inform; 2011 Jan; 30(1):35-44. PubMed ID: 27467876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicomplex-based pharmacophore-guided 3D-QSAR studies of N-substituted 2'-(aminoaryl)benzothiazoles as Aurora-A inhibitors.
    He G; Qiu M; Li R; Ouyang L; Wu F; Song X; Cheng L; Xiang M; Yu L
    Chem Biol Drug Des; 2012 Jun; 79(6):960-71. PubMed ID: 22381081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico prediction of blood-brain barrier permeability.
    Yan A; Liang H; Chong Y; Nie X; Yu C
    SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase-targeted library design through the application of the PharmPrint methodology.
    Deanda F; Stewart EL; Reno MJ; Drewry DH
    J Chem Inf Model; 2008 Dec; 48(12):2395-403. PubMed ID: 19053525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of support vector machine (SVM) for prediction toxic activity of different data sets.
    Zhao CY; Zhang HX; Zhang XY; Liu MC; Hu ZD; Fan BT
    Toxicology; 2006 Jan; 217(2-3):105-19. PubMed ID: 16213080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of selective aminothiazole aurora kinase inhibitors.
    Andersen CB; Wan Y; Chang JW; Riggs B; Lee C; Liu Y; Sessa F; Villa F; Kwiatkowski N; Suzuki M; Nallan L; Heald R; Musacchio A; Gray NS
    ACS Chem Biol; 2008 Mar; 3(3):180-92. PubMed ID: 18307303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors.
    Belanger DB; Curran PJ; Hruza A; Voigt J; Meng Z; Mandal AK; Siddiqui MA; Basso AD; Gray K
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5170-4. PubMed ID: 20674350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors.
    Qu D; Yan A; Zhang JS
    SAR QSAR Environ Res; 2017 Feb; 28(2):111-132. PubMed ID: 28235391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine.
    Fatemi MH; Gharaghani S
    Bioorg Med Chem; 2007 Dec; 15(24):7746-54. PubMed ID: 17870538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.